somal system for sex determination. The presence of SRY, a masterregulatory gene on the Y chromosome, is necessary to induce the undifferentiated, bipotential gonadal primordium (the embryonic genital ridge) to develop as a testis. In the absence of SRY, it develops as an ovary I. Once the gonads differentiate, their maleor female-specific endocrine function is responsible for the rest of the events involved in the pheno~pic ~_~..'.=l diffcrenuation process 2. Accordingly, in mammals, sex determination can be equated with testis determination.
SRY is the only gene currently known to be involved in the process of sex determination. A number of cloned genes probably participate in gonadal development: the Mtillerian inhibiting substance gene (MIS; also called the antimiillerian hormone gene, AMH)3, the SRY-related gene, SOX9 (ReL 4), the mouse gene encoding steroidogenic factor (SF1), FtzF1 (Ref. 5) , the X-linked gene, DAXI (Refs 6, 7), and the Wilm's tumor suppressor gene, WT1 (Ref. 8) . Whereas MIS and SOX9 are probably involved in the male pathway, the moment and site of action of the rest of these genes in the sex-differentiation process is unclear. FtzF1 and WT1 might be involved in the formation of the bipotential gonad, thus acting before SRY. The female pathway remains almost completely unknown. An X-linked, dosage-sensitive gene (DSS), which might be identical to DAXI, causes male-tofemale sex reversal when duplicated, anti has been proposed to be a member of the female pathway 9.1°, but the findings on this point are inconclusive (see below). Therefore, mammalian sex-determination is, in fact, an unsolved genetic puzzle from which a number of pieces are probat~ly still missing.
The Z-gene model Several general models for mammalian sex determination have been PAZ~JE LAS LAGUN11. L~ S/N, 23071JA~, SPAL' q.
proposed in the last ten yeats 3,11,12, but as originally described, none of them provide a plausible explanation for most reported cases with sex anomalies. One of the more recent models, proposed by McElmavey et al. t3.t4 suggests that the SRVgene functions by inhibiting "a further regulatory gene, Z, which is, in turn, an inhibitor of the male pathway. The possible role of SRYas an inhibitor of downstream target genes has aim been considered by other authors 1,15-17. The Z-gene model implies that a gene (or genes) other than SRY directly controls target genes in the male pathway, a view contradicted by the more usually accepted (though not demonstrated) hypothesis that SRY directly activates a testis-determining cascade. This latter hypothesis is suppol~ed by three facts: (1) the human SRY product, SRY, has a DNA-binding and -bending domain (the HMG box), so that it probably acts as a transcription factort; (2) the mouse SRY protein can function as a transcriptional activator in vitro, although human SRY cannotls; and (3) when SRY is transfected into a rat gonadalridge-derived cell line, SRY induces (although not directly) the expression of MIS, a gene probably involved in testis development3.
However, it is not clear that mouse or human SRY acts as a transcriptional activator in vivo at the moment of testis determination. In fact, the activator domain of the mouse SRY protein is not evolutionarily consen,ed TM. Furthermore, the fact that SRY-negatire XX humans can develop, although rarely, as phenotypically normal males without sexual ambiguities 13 and, more interestingly, the finding that two mole-vole species (genus Ellobius) determine sex in the absence of the Y chromosome and the 5~Y gene 192°, are consistent with the Z-gene model: these findings clearly demonsLrate that correct male development can be induced in the absence of SRY. A simple explanation for the situation in Ellobtus is to assume that SRY was TIG MAY 1996 VOL. 12 No. 5 present in the ancestor of this genus, and was lost in the two SRY-negative species (some Ellobius species have SRY, whereas others lack it).
The/Ii~-gene model A recently described gene, DSS (dosage-sensitive sex reversalg), located on the short arm of the human X chromosome (Xp21 region), induces XY individuals with an apparently i,",:actSRYto deveiop as tbmales when two active copies of DSS are present (duplication of Xp21). Because XXY individuals with Klinefelter syndrome are essentially males, this gene is assumed to be subject to X inactivation. The fact that DSS-negative, 46,XY patients can develop male external genitalia suggests that this gene is not involved in testis development. Hence, DSS might be an inducer of the female sex pathway3,9,10, but it is also possible for this gene to act by repressing the male pathway. It is well known that mammalian testicular differentiation precedes ovarian differentiation during fetal development. Accordingly, to obtain a female from an XY embryo with an intact SRY, testis differentiation would have to be inhibited before the activation of ovarian-specific genes. If DSSis, in fact, a suppressor of the male pathway, it would not be expected to act by repressing SRYdirectly, because in this case its existence would be difficult to justify: its suppressing action would not be required in XX females (because they are SRYnegative), anti this action would not be desired in XY males.
In accordance with these considerations, we propose that a single active copy of DSS can repress the male pathway in normal XX females, but not in XY males, where it is inactivated by the SRYgene. This implies that the Z and the DSS genes are identical, and that Z is not autosomal as originarily proposed, but X-linked as is DSS, a location also consistent with the pedigrees analyzed by McElreavey et aL 13.
COMMENT
Any model for mammalian sex determination has to take into account other important aspects of the process, such as the developmental timing of normal male and female pathways. The fact that ovarian tissue can transdifferentiate into testicular tissue at anytime of development or adult life (reviewed in Ref. 21) suggests: (1) that male pathway genes (MPGs) must be permanently inhibited to permit correct female development and functionality; and (2) that this inhibition can be exerted by different favors at different moments of pre-or post_natal life. According to the DSS-gene model (Fig. la) , in XY individuals MPGs could be active at the moment of normal testis differentiation, because the copy of DSS is inhibited by SRY. Activation of MPGs at the time of normal testis differentiation would generally lead to the development of phenotypically normal males (e.g. no..,mai XY males and fully sex-reversed XX males without sexual ambiguities).
In 3'7X individuals (Fig. lb) , the absence of SRY allows DSS to keep MPGs inactive, and female pathway genes (FPGs) are activated later in development. Several facts indicate that functional ovarian tissue is necessary to avoid further activation of MPGs and subsequent transdifferentiation into testicular tissue. In all cases described up to now, transdifferentiation has been shown to occur only after oocyte depletionZt, 22. It has also been reported that germ cell deficiency causes testis cord differentiation in reconstituted mouse fetal ovaries 23. Accon:'rtgly, we propose that after ovarian differentiation, MPGs are no longer inhibited by DSS (this gene is expected to be oocyte independent and to act eadier, coinciding with SRY) but, rather, by oocytes. Late activation of MPGs would generally give rise to abnormally differentiated testicular tissue and, hence, to individuals with incomplete sex reversal [e.g. freemartins or XX true hermaphrodites, such as the fertile females with ovotestes described in insectivorous moles of genus Talpa (Refs 24, 25)].
Implications, predictions and lm's~es
This model provides a rational exp!anation not only for the cases of XX and XY sex reversal currently known to occur in humans and other mammals (Fig. 1) , but also for some intriguing features of the sex reversal process. As originally argued by McElreavey et el)5, individuals homozygous for loss-of-function mutant Z alleles (Z-) would develop as XX males without sexual ambiguities, and indMduals homozygous for Z mutant alleles insensitive to the action of SRY(Z t) would be XY females. These authors also proposed the existence of several 'leaky' Z mutants that conserve some residual activity, to explain the variability in sex phenotype among XX sex-reversed humans (from almost normal males to almost normal females, including a variety of intersex forms). However, the DSS-gene model provides an alternative explanation. These individuals could be heterozygous for a DSS-allele, so that the proportion of cells of the gonadal primordium in which the normal allele (DSSO is affected by X-inactivation would determine the degree of residual maleness exhibited by a given indMdual. In fact, this situation is similar to that described in T16H/X sxr TIG MAY 1996 VOL. 12 NO. 5 165 mice 2627. These XX mice have a sexreversal factor, Sxr (which contains Sty), attached to one X chromosome. In addition the X-autosome translocation T(X;16)16H (T16H) is present on the other X chromosome. Owing to the X-autosome translocation, the Sxr-bearing X is kept inactive in most, if not all, somatic cells. As a consequence of variable escape liom inactivation, these individuals can develop as males, females or intersexes.
The existence of fertile human XX females with Xp deletions or duplications 9,2s is also consistent with the DSS-gene model: (1) DSSduplications would have no negative effects on normal female development, because inhibition of MPGs would be even stronger under these conditions than in normal females; (2) as with XX individuals heterozygous for loss-offunction DSS-mutations, the few XX fertile females with a deletion of one DSS locus could represent "the female extreme of a wide range of sexual phenotypes expected to occur as a conscquence of X-inactivation (see above).
The fact that 46,XY patients with a complete deletion of the DSS region can have male external genitalia suggests that this gene does not play a major role in testis differentiation 9. However, this phenotype is easily explained if DSSis a suppressor oftbe male pathway. Deletion of DSSwould be expected to have no effect on the normal testicular development of XY individuals under these circumstances. This raises interesting predictions that could be tested in the mouse when the homologous gene of this species, Dss, is isolated. Because the Y chromosome would not be necessary to induce testis differentiation, X0 males could be produced if they are Dss negative. Furthermore, individuals with duplicated Dss could be males if they have two or more active copies of Sry (e.g. XYY or XY sxr mice with duplicated Dss).
A recently cloned gene, DAX1, also located at the 160kb fragment of the Xp21 region that contains DSS, "has been shown to induce adrenal hypoplasia congenita and hypogonadotropic hypogonadism when deleted or mutated 6.7. This gene encodes a nuclear hormone receptor related to SF1 (see above) 5. .Although there is little supporting evidence, it has been suggested (1) that DAX1 is identical to DSS(Ref. 7); (2) that it can respond to maternal hormonesl0; and (3) that an increased dosage of this gene could override the action of SRE thus leading to female development t°. If these hypotheses are correct they are consistent with the DSS-gene model because, in evtflutionary terms of maleversus-female gene competition 29,3°, a gene responding to maternal hormones could have been recmited into a genetic system that inhibits testis developme0t. In this connection, it has been demonstrated that DAX1 binds to DNA and acts as a dominant-negative regulator of transcription mediated by the retinoic acid receptor 7.
The DSS-gene model for mammalian sex determination assumes that DSS i*; inactivated either directly or indirectly by SRY, a'~t that DSS itself can inhibit the male pathway. It is, therefore, a negative regulatory ca,~ade, which would be reminiscent t~f that demonstrated for nematode sex determination31. It has been suggested that such a system must evolve backwards from the most downstream to the most upstream element 32, which implies that, in mammals, the last gene incorporated would have been SRY. It is known (1) that SRYis present in mammals but not in birds or reptiles33; (2) that it controls all events of sex differentiation in eutherians but not in marsupials; (3) that its presence is dispensable in two eutherian species (Ellobius mole voles) which, nevertheless, determine sex20; and (4) that all female moles of the genus Ta/pa develop ovotestes in the absence of SRY (Refs 24, 25) . These features suggest that SRY was acquired relatively recendy by a more primitive sex-determination system, which in marsupials might be based on the ratio of X chromosomes:autosomes t°.34 (X linked and dosage dependent, therefore). If DSS is the second gene of a mammalian negative-regulation cascade, then it could be the dosage-dependent major sex-determining gene in birds or mole rats, and it could determine the scrotum or pouch in marsupials. However, genes on the human Xp region are autosomal in marsupials 3~, so that it is not clear that DSS is X linked in these mammals.
In conclusion, we propose a new genetic model that is compatible with many discoveries concerning sex determination and sex reversal in mammals. However, these processes are complicated and also involve important roles for hormones and growth factors. Consequently, sex determination and sex reversal might not be explicable in purely genetic tetras. Cloning the hurmm and mouse DSS ( Dss ) gene ( DAX1 or Da x l ? ) will make it possible to test our model. The development of X0 male mice and males with duplicated Dss and S.rv genes, and the study of the genetic features of DSS in birds, marsupials and Ellobius, should also help to shed light on the mechanism we propose, so that it might one day be possible to assemble all the pieces of this most intricate and challenging puzzle.
